Product overview
Type
Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type b-Polio (Inactivated)
Commercial Name
HEXASIIL
Manufacturer
Serum Institute of India Pvt. Ltd.
Manufacturer Country
India
Responsible NRA
Central Drugs Standard Control Organization
Country
India
URL
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
10
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
24 months
Storage Temperature
2-8°C
Secondary Packaging
Carton of 50 vials (500 doses). Dimensions: 18.5 x 9.5 x 6.0 cm
Tertiary Packaging
Carton fo 300 vials (3000 doses). Dimensions: 31.0 x 19.0 x 13.3 cm]. Shipping box containing 1200 vials (12000 doses) [Dimensions: 71.5 x 60.5 x 63.5 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
2-phenoxyethanol
Vaccine Preservative Concentration
0.5%
Cold Chain Volume
2.11 cm3/dose (in secondary packaging)